Plasma pentazocine radioimmunoassay. 1979

J E Peterson, and M Graham, and W F Banks, and D Benziger, and E A Rowe, and S Clemans, and J Edelson

A sensitive and specific radioimmunoassay of dog and human plasma pentazocine is described. Rabbit antiserum and the second antibody method separated bound from free pentazocine. The radioimmunoassay employed an 125I-labeled radioligand and required extraction from the sample prior to quantitation. The method had a detection limit of approximately 200 pg/assay tube (1 ng/ml). The assay was used successfully to measure pentazocine in the plasma of beagle hounds given 0.3 mg of pentazocine/kg iv. The decline in plasma levels fitted a two-compartment body model with a 100-min mean overall half-life and a 3.2-liters/hr mean plasma clearance rate.

UI MeSH Term Description Entries
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010423 Pentazocine The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97) Fortral,Lexir,Pentazocine Hydrochloride,Pentazocine Lactate,Talwin,Hydrochloride, Pentazocine,Lactate, Pentazocine
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J E Peterson, and M Graham, and W F Banks, and D Benziger, and E A Rowe, and S Clemans, and J Edelson
January 1974, Research communications in chemical pathology and pharmacology,
J E Peterson, and M Graham, and W F Banks, and D Benziger, and E A Rowe, and S Clemans, and J Edelson
May 1973, Journal of pharmaceutical sciences,
J E Peterson, and M Graham, and W F Banks, and D Benziger, and E A Rowe, and S Clemans, and J Edelson
January 1974, The Journal of nuclear biology and medicine,
J E Peterson, and M Graham, and W F Banks, and D Benziger, and E A Rowe, and S Clemans, and J Edelson
July 1971, Steroids,
J E Peterson, and M Graham, and W F Banks, and D Benziger, and E A Rowe, and S Clemans, and J Edelson
February 1978, Clinical biochemistry,
J E Peterson, and M Graham, and W F Banks, and D Benziger, and E A Rowe, and S Clemans, and J Edelson
August 1974, Journal of steroid biochemistry,
J E Peterson, and M Graham, and W F Banks, and D Benziger, and E A Rowe, and S Clemans, and J Edelson
January 1974, Clinical endocrinology,
J E Peterson, and M Graham, and W F Banks, and D Benziger, and E A Rowe, and S Clemans, and J Edelson
April 1972, Zeitschrift fur klinische Chemie und klinische Biochemie,
J E Peterson, and M Graham, and W F Banks, and D Benziger, and E A Rowe, and S Clemans, and J Edelson
May 1971, The Journal of clinical endocrinology and metabolism,
J E Peterson, and M Graham, and W F Banks, and D Benziger, and E A Rowe, and S Clemans, and J Edelson
May 1977, American journal of obstetrics and gynecology,
Copied contents to your clipboard!